DUBLIN–(BUSINESS WIRE)–The “Dry Eye Syndrome Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026” report has been added to ResearchAndMarkets.com’s offering. The global dry eye syndrome market reached a value of US…
Author: Business Wire
Adult Myopia Epidemiology Market Forecast Report 2018-2030: Focus on United States, Germany, Spain, Italy, France, United Kingdom, and Japan – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Adult Myopia – Epidemiology Forecast to 2030” report has been added to ResearchAndMarkets.com’s offering. This ‘Adult Myopia-Epidemiology Forecast – 2030’ report delivers an in-depth understanding of the historical and for…
Inflammasome Therapeutics’ Kamuvudines May Be Answer to Preventing Blindness in Aging Population
NEWTON, Mass.–(BUSINESS WIRE)– #AMD–Inflammasome Therapeutics’ Kamuvudines may be answer to preventing blindness in aging population. Research published last week points to potential.
Fabrinet to Announce Third Quarter 2021 Financial Results on May 3, 2021
BANGKOK, Thailand–(BUSINESS WIRE)– #EarningsDate–Fabrinet (NYSE: FN), a leading provider of advanced optical packaging and precision optical, electro-mechanical and electronic manufacturing services to original equipment manufacturers of complex pro…
Aerie Pharmaceuticals Receives Marketing Authorisation of Roclanda® 50 micrograms/ml + 200 micrograms/ml Eye Drops, Solution (latanoprost + netarsudil) in Great Britain
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glauco…
Bollé Safety Now Offers Trivex Options for Its Prescription Safety Lenses
VILLEURBANNE, France–(BUSINESS WIRE)–Global eye protection specialist Bollé Safety now provides Trivex. A high-performance, high-technology prescription lens providing maximum security and great optical properties to ensure the best safety in a work …
Gyroscope Therapeutics Files Registration Statement for Proposed Initial Public Offering in the United States
LONDON–(BUSINESS WIRE)–Gyroscope Therapeutics files registration statement for proposed initial public offering in the United States.
Advanced Eye Protection Against Covid-19 For Healthcare Professionals – an Exclusive Bollé Safety Technology
VILLEURBANNE, France–(BUSINESS WIRE)–Bollé Safety, world leader in the design and manufacture of protective eyewear, presents its new products dedicated to all healthcare professionals.
Global Glaucoma Surgery Devices Market to 2030 – Analysis and Forecast Model – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Glaucoma Surgery Devices (Ophthalmic Devices) – Global Market Analysis and Forecast Model (COVID-19 Market Impact)” report has been added to ResearchAndMarkets.com’s offering. This report was built to visualize quantitativ…
New Long-Term Data for UPLIZNA® (inebilizumab-cdon) in People Living with Neuromyelitis Optica Spectrum Disorder (NMOSD)
DUBLIN–(BUSINESS WIRE)–Horizon Therapeutics today announced new UPLIZNA® (inebilizumab-cdon) data being presented at the American Academy of Neurology 2021 Annual Meeting.
New Integrated Data and Follow-up Outcomes From Two TEPEZZA® (teprotumumab-trbw) Pivotal Trials Published in The Lancet Diabetes & Endocrinology
DUBLIN–(BUSINESS WIRE)–Horizon Therapeutics announced pooled data from the TEPEZZA® (teprotumumab-trbw) clinical trials are published in The Lancet Diabetes & Endocrinology.
New Data for Genentech’s Ocrevus (ocrelizumab) Reinforce Significant Benefit on Slowing Disease Progression in Relapsing and Primary Progressive Multiple Sclerosis
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced new Ocrevus® (ocrelizumab) analyses supporting its significant benefit on disease progression in early-stage relapsing-re…
2021 Report on Global Ophthalmic Viscoelastic Devices (Ophthalmic Devices) – Market Analysis and Forecast Model – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Ophthalmic Viscoelastic Devices (Ophthalmic Devices) – Global Market Analysis and Forecast Model (COVID-19 Market Impact)” report has been added to ResearchAndMarkets.com’s offering. This report discusses in detail the imp…
Qlaris Bio Enrolls First Patient in Phase 1/2 Studies of QLS-101, an Investigational Therapy Designed to Lower Episcleral Venous Pressure (EVP) in Patients with Glaucoma
WELLESLEY, Mass.–(BUSINESS WIRE)–Qlaris Bio today announced the enrollment of the first patient in its Phase 1/2 clinical program for QLS-101.
Glaukos Corporation to Release First Quarter 2021 Financial Results after Market Close on May 5
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, plans to release firs…
Katena Products Announces the Acquisition of ASICO, LLC.
PARSIPPANY, N.J.–(BUSINESS WIRE)–Katena Products, Inc. (Katena) a leading global provider of premium ophthalmic instruments, biologics, and devices to hospitals, surgical centers, and ophthalmic and optometric offices announces the purchase of ASICO,…
Aura Biosciences Announces Publication of Data in Cancer Immunology Research, Supporting the Immune Mediated Mechanism of Action of the Virus-Like Drug Conjugate (VDC) Technology Platform with Broad Application in Cancer Treatment
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Aura Biosciences, a clinical-stage oncology company developing a novel class of virus-like drug conjugate (VDC) therapies for multiple oncology indications, today announced the online publication of data in the peer-r…
Kopin To Participate in New Webinar Series – AR and VR: The Paradigm Shift to Smartglasses Starts Now
WESTBOROUGH, Mass.–(BUSINESS WIRE)–Kopin® Corporation (NASDAQ: KOPN), a leading developer and provider of transmissive and reflective active matrix liquid crystal and organic light emitting diode (OLED) microdisplays used in military, enterprise, ind…
ProtoKinetix Engages Multi-National Partner for Formulation of Topical Drug to Treat Dry Eye Disease & Ocular Inflammation with AAGP®
MARIETTA, Ohio–(BUSINESS WIRE)—- $PKTX #AAGP–ProtoKinetix Engages Multi-National Partner for Formulation of Topical Drug to Treat Dry Eye Disease & Ocular Inflammation with AAGP®
AmeriHealth Caritas Selected to Serve Ohio’s Medicaid and CHIP Populations
PHILADELPHIA–(BUSINESS WIRE)– #Medicaid–AmeriHealth Caritas has been selected by Ohio Department of Medicaid to serve Ohio’s Medicaid managed care program.